Meis Moukayed

Prof. Meis Moukayed

American University in Dubai, Dubai, Dubayy, United Arab Emirates
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2013 in Nutrients
Verified
Journal Article
Open access
PDF file
Meis MoukayedMeis Moukayed
Meis Moukayed
William B. GrantWilliam B. Grant
William B. Grant
The metabolite of vitamin D, 1α,25-dihydroxyvitamin D3 (also known as calcitriol), is a biologically active molecule required to maintain the physiological functions of several target tissues in the human body from conception to adulthood. Its molecular mode of action ranges from immediate nongenomic responses to longer term mechanisms that exert persistent genomic effects. The genomic mechanisms of vitamin D action rely on cross talk between 1α,25-dihydroxyvitamin D3 signaling pathways and that of other growth factors or hormones that collectively regulate cell proliferation, differentiation and cell survival. In vitro and in vivo studies demonstrate a role for vitamin D (calcitriol) in modulating cellular growth and development. Vitamin D (calcitriol) acts as an antiproliferative agent in many tissues and significantly slows malignant cellular growth. Moreover, epidemiological studies have suggested that ultraviolet-B exposure can help reduce cancer risk and prevalence, indicating a potential role for vitamin D as a feasible agent to prevent cancer incidence and recurrence. With the preventive potential of this biologically active agent, we suggest that countries where cancer is on the rise—yet where sunlight and, hence, vitamin D may be easily acquired—adopt awareness, education and implementation strategies to increase supplementation with vitamin D in all age groups as a preventive measure to reduce cancer risk and prevalence.

21 December 2006 in Stem Cells
Verified
Journal Article
Open access
PDF file
EMEnca Martin-Rendon
Enca Martin-Rendon
SHSarah J.M. Hale
Sarah J.M. Hale
DRDacey Ryan
Dacey Ryan
DBDilair Baban
Dilair Baban
SFSinead P. Forde
Sinead P. Forde
SWSuzanne M. Watt
Suzanne M. Watt
Umbilical cord blood (UCB) and bone marrow (BM)-derived stem and progenitor cells possess two characteristics required for successful tissue regeneration: extensive proliferative capacity and the ability to differentiate into multiple cell lineages. Within the normal BM and in pathological conditions, areas of hypoxia may have a role in maintaining stem cell fate or determining the fine equilibrium between their proliferation and differentiation. In this study, the transcriptional profiles and proliferation and differentiation potential of UCB CD133+ cells and BM mesenchymal cells (BMMC) exposed to normoxia and hypoxia were analyzed and compared. Both progenitor cell populations responded to hypoxic stimuli by stabilizing the hypoxia inducible factor (HIF)-1α protein. Short exposures to hypoxia increased the clonogenic myeloid capacity of UCB CD133+ cells and promoted a significant increase in BMMC number. The differentiation potential of UCB CD133+ clonogenic myeloid cells was unaltered by short exposures to hypoxia. In contrast, the chondrogenic differentiation potential of BMMCs was enhanced by hypoxia, whereas adipogenesis and osteogenesis were unaltered. When their transcriptional profiles were compared, 183 genes in UCB CD133+ cells and 45 genes in BMMC were differentially regulated by hypoxia. These genes included known hypoxia-responsive targets such as BNIP3, PGK1, ENO2, and VEGFA, and other genes not previously described to be regulated by hypoxia. Several of these genes, namely CDTSPL, CCL20, LSP1, NEDD9, TMEM45A, EDG-1, and EPHA3 were confirmed to be regulated by hypoxia using quantitative reverse transcriptase polymerase chain reaction. These results, therefore, provide a global view of the signaling and regulatory network that controls oxygen sensing in human adult stem/progenitor cells derived from hematopoietic tissues.Disclosure of potential conflicts of interest is found at the end of this article.



24 June 2021
Verified
Book
Open access
Meis MoukayedMeis Moukayed
Meis Moukayed
PVPier Vellinga
Pier Vellinga
EBEdward Barrett-Lennard
Edward Barrett-Lennard
RCRedouane Choukr-Allah
Redouane Choukr-Allah
TETheo Elzenga
Theo Elzenga
<!----> <!----> Food production on present and future saline soils deserves the world’s attention particularly because food security is a pressing issue, millions of hectares of degraded soils are available worldwide, freshwater is becoming increasingly scarce, and the global sea-level rise threatens food production in fertile coastal lowlands. Future of Sustainable Agriculture in Saline Environments aims to showcase the global potential of saline agriculture. The book covers the essential topics, such as policy and awareness, soil management, future crops, and genetic developments, all supplemented by case studies that show how this knowledge has been applied. It offers an overview of current research themes and practical cases focused on enhancing food production on saline lands. FEATURES Describes the critical role of the revitalization of salt-degraded lands in achieving sustainability in agriculture on a global scale Discusses practical solutions toward using drylands and delta areas threatened by salinity for sustainable food production Presents strategies for adaptation to climate change and sea-level rise through food production under saline conditions Addresses the diverse aspects of crop salt tolerance and microbiological associations Highlights the complex problem of salinity and waterlogging and safer management of poor-quality water, supplemented by case studies A PDF version of this book is available for free in Open Access at www.taylorfrancis.com. It has been made available under a Creative Commons Attribution-Non Commercial-No Derivatives 4.0 license. <!----> <!---->

1 August 2019 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
Meis MoukayedMeis Moukayed
Meis Moukayed
William B. GrantWilliam B. Grant
William B. Grant
The global death toll from noncommunicable diseases is exceptionally high, reported to cause 71% of global deaths worldwide. Metabolic syndrome risk factors, especially excessive adiposity and obesity, are at the heart of the problem resulting in increased co-morbidities such as cardiometabolic diseases and cancer, increased health costs, poorer quality of life, and shortened survival. Vitamin D3 can positively reverse many of these adverse effects and outcomes through blocking signaling mechanisms that predispose to cardiometabolic and metastatic disease. As an affordable natural agent, vitamin D3 can be used to counteract obesity-induced inflammation, block early adipogenesis, enhance glucose uptake, counteract hyperleptinemia, ameliorate insulin resistance, and reduce hypertension. This is supported by data from in vitro, in vivo and epidemiological studies and clinical trials. We propose that everyone in general and obese patients in particular consider raising 25-hydroxyvitamin D levels through UVB exposure and/or supplemental vitamin D3 intake to reduce cardiometabolic and metastatic disease and increase longevity.